Project description
Novel prebiotics
The gut microbiota – the microorganisms that reside in the gastrointestinal tract – help maintain our health as they prohibit colonisation by pathogenic bacteria. The gut microbiota digest dietary fibres found in fruit, grains and vegetables known as prebiotics. Because modern diet often lacks essential dietary fibres, prebiotics have been introduced as supplements. The EU-funded BioAXOS project has developed novel prebiotic solutions as soluble ingredients that can be incorporated into pet and human food or used in nutraceutical applications. The extraction and isolation processes of these prebiotics are cost-effective as they can be accommodated by grain milling facilities or bioethanol production plants.
Objective
Prebiotics (just like other fibres) are carbohydrates—humans do not digest them, but probiotic bacteria in our gastrointestinal tracts flourish on them, making it more difficult for dangerous pathogenic bacteria to multiply. Prebiotics occur naturally in many fruits & vegetables—in chicory roots, avocados, peas, dandelion greens, as well as in whole & sprouted grains. There is a growing body of clinical studies & other scientifical evidence attesting to their positive effect on our health.
At the moment the most widely used prebiotic is inulin (40%+ market share). More efficient recent prebiotics, XOS and more recently AXOS have attracted a lot of attention , since they substantially improves on other characteristics of other types of prebiotics.
We have developed BioAXOS—a novel effective prebiotic from XOS family that fulfils the described criteria can replace inulin in at least half of its applications, taking a market share of at least 20%. In the EU only this represents a total addressable market of €200m. This process can be run on any bioethanol production plant (or grain milling facility) enabling additional revenue streams for them. As a result of our Phase 1 feasibility study we have secured a strategic partnership with Pannonia Ethanol to produce BioAXOS, which will accelerate our time to market by 2 years.
With BioAXOS we are targeting at least 10% of the total prebiotics market by 2027, and at least 40% in the longer term.
In this Phase 2 project we are requesting a €1.9m contribution to industrialize the BioAXOS process, undergo necessary regulatory approval to be able to sell into human food applications, as well as carry out 3 trials with functional food producers.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques.
- medical and health scienceshealth scienceshealth care sciences
- medical and health sciencesbasic medicineimmunologyautoimmune diseases
- natural scienceschemical sciencesorganic chemistryalcohols
- medical and health scienceshealth sciencesnutritionobesity
You need to log in or register to use this function
Programme(s)
- H2020-EU.3.2. - SOCIETAL CHALLENGES - Food security, sustainable agriculture and forestry, marine, maritime and inland water research, and the bioeconomy Main Programme
- H2020-EU.3.2.4. - Sustainable and competitive bio-based industries and supporting the development of a European bioeconomy
- H2020-EU.3.2.1. - Sustainable agriculture and forestry
- H2020-EU.2.3.1. - Mainstreaming SME support, especially through a dedicated instrument
- H2020-EU.3.2.2. - Sustainable and competitive agri-food sector for a safe and healthy diet
Funding Scheme
SME-2 - SME instrument phase 2Coordinator
D6WFE82 Dublin
Ireland
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.